Qualitative study of Oncology Clinicians' Perceptions of Barriers to Offering Clinical Trials to Underserved Populations.
Giselle K PerezAnjali R OberoiLucy Finkelstein-FoxElyse R ParkRyan D NippBeverly MoyPublished in: Cancer control : journal of the Moffitt Cancer Center (2023)
Findings reveal multi-level barriers to offering cancer clinical trials to underrepresented patients. Targeted solutions, including system level changes to support clinicians, patient financial support, and implementation of clinical trial navigation programs were recommended to help reduce access barriers and increase enrollment of underrepresented patients into cancer clinical trials.
Keyphrases
- clinical trial
- end stage renal disease
- healthcare
- ejection fraction
- palliative care
- newly diagnosed
- chronic kidney disease
- primary care
- phase ii
- public health
- prognostic factors
- papillary thyroid
- open label
- randomized controlled trial
- gene expression
- phase iii
- young adults
- childhood cancer
- patient reported outcomes
- double blind
- patient reported
- lymph node metastasis